Partager

Document IIF

Nouvelles recommandations pour la qualité et la sécurité des tissus et cellules destinés à une application clinique et leur importance pour l'activité des établissements pratiquant la cryoconservation des tissus.

New recommendations for the quality and safety of tissues and cells for clinical application and its significance for the practice of tissue establishments performing cryopreservation.

Numéro : 0038

Auteurs : MERICKA P., JANDOVA M., GREGOR J., STERBA L.

Résumé

The processess of procurement, processing, storage and distribution of cells and tissues of human origin used for clinical application are regulated in the European Union member states by the Directive of the European Parliament and Council No.2004/23/EC harmonized in the Czech Republic by the Act No. 296/2008 Coll. and the Decree of the Ministry of Health No. 422/2008 Coll. These norms settled minimal requirements for the practice of Procurement and Tissue Establishment (TE) licensed and regularly inspected by the national competent authorities, such as the State Institute for Drug Control in the Czech Republic. In the framework of evaluation of fulfilling of requirements of the above mentioned Directive in individual member states performed in 2019 the European Commission pointed out the significance of the document: “Guide to the Quality and Safety of Tissues and Cells for Human Application“, the 4th Edition, issued by the European Directoriate for the Quality of Medicines in 2019. The document includes specifications of cryopreserved haematopoietic progenitor cells derived from bone marrow, peripheral blood and cord blood as well as of non-mobilized peripheral blood mononuclear cells. The cryoprotectant dimethyl sulfoxide (DMSO) is recommended to be used in concentrations 5 – 10 % (v/v) and in the daily dose not exceeding 1 g per kg of the patient´s weight. DMSO removal before clinical administration is recommended to be performed in specific situations defined in the standard operating procedures of the TE. A guide defining Good Tissue Practice is a part of this document. It can be expected that the document represents a basis for the planed upgrade of the Directive 2004/23/EC and of the Commission Directives 2006/17/EC and 2006/86/EC.

Documents disponibles

Format PDF

Pages : 6

Disponible

  • Prix public

    20 €

  • Prix membre*

    Gratuit

* meilleur tarif applicable selon le type d'adhésion (voir le détail des avantages des adhésions individuelles et collectives)

Détails

  • Titre original : New recommendations for the quality and safety of tissues and cells for clinical application and its significance for the practice of tissue establishments performing cryopreservation.
  • Identifiant de la fiche : 30029027
  • Langues : Anglais
  • Source : Cryogenics 2021 online. Proceedings of the 16th IIR International Conference, October 5-7, 2021.
  • Date d'édition : 05/10/2021
  • DOI : http://dx.doi.org/10.18462/iir.cryo.2021.0038
  • Document disponible en consultation à la bibliothèque du siège de l'IIF uniquement.

Liens


Voir d'autres communications du même compte rendu (36)
Voir le compte rendu de la conférence

Indexation